CLINICAL_TRIALS
trial_result
· 2023-12-11
Clinical Trial Update: SYR-472 Open-label Study [Phase 3]
Summary
An open-label Phase 3 clinical trial update for SYR-472 in diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED